STOCK TITAN

Lexaria Bioscience Corp (LEXX) Net Income by Year

LEXX

Lexaria Bioscience Corp reported a net loss of $11.9M in fiscal year 2025. This represents a decrease of 105.4% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to a $7.7M net loss. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lexaria Bioscience Corp has filed alongside them.

FY2025 annual
Net Income -$11.9M
YoY -105.4%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended May 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LEXX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$7.7M-$11.9M-105.4%-$5.8M+13.0%-$6.7M+8.3%-$7.3M-80.5%-$4.0M+1.4%-$4.1M-199.6%$4.1M-37.9%$6.6M+442.1%-$1.9M-51.1%-$1.3M+35.6%-$2.0M-27.2%-$1.6MN/AN/A-$538K

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

LEXX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Net Income-$2.0M+47.4%-$1.4M+46.6%-$1.6M+41.0%-$2.7M-23.4%-$3.8M-112.7%-$2.7M-317.7%-$2.7M-129.3%-$2.2M-76.3%-$1.8M+24.9%-$650K+50.0%-$1.2M+32.8%-$1.2M+15.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Lexaria Bioscience Corp financials

Frequently Asked Questions

What was Lexaria Bioscience Corp's net income in fiscal year 2025?

Lexaria Bioscience Corp reported a net loss of $11.9M in fiscal year 2025.

How fast is Lexaria Bioscience Corp's net income growing?

Lexaria Bioscience Corp (LEXX) net income fell by 105.4% year over year, from -$5.8M to -$11.9M in fiscal year 2025.

What is Lexaria Bioscience Corp's net income over the last twelve months?

Lexaria Bioscience Corp (LEXX) reported a $7.7M net loss over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Lexaria Bioscience Corp (LEXX) net income went from -$538K in fiscal year 2011 to -$11.9M in fiscal year 2025.

Lexaria Bioscience Corp (LEXX) reported -$2.0M in net income in Q3 2026. This represents an increase of 47.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Lexaria Bioscience Corp (LEXX) reported on that line in every period on record.